Navigation Links
StoredIQ Shares Expertise at IQPC's eDiscovery Pharma, Biotech and Medical Device Conference
Date:9/10/2009

AUSTIN, Texas, Sept. 10 /PRNewswire/ --

WHO: Panel of leading eDiscovery experts including Dan Junk, Esq., VP of Business Development, StoredIQ

WHEN: Tuesday, September 15th

9:50 a.m. ET

WHERE: IQPC's 4th Conference on eDiscovery for Pharma, Biotech & Medical Device Industries

The Hub Cira Centre -- Philadelphia, PA

TOPIC: Cost-Benefit Analysis of In-house eDiscovery Tools vs. Outsourcing Help

DESCRIPTION:

Product liability lawsuits, patent disputes, class action claims, and regulatory investigations continue to challenge healthcare companies. IQPC's 4th Conference on eDiscovery for Pharma, Biotech & Medical Device Industries, focuses on eDiscovery and retention specifically for the highly regulated and litigious drug and medical device markets.

Addressing the cost and benefits of bringing eDiscovery in-house, StoredIQ's Vice President of Business Development, will take part in a panel discussion which includes Dr. Ellen Voorhees, TREC Project Manager from the National Institute of Standards and Technology and Huong Nyugen, Director of Intellectual Property from Impax Laboratories. Panel discussions will center on:

  • Examining how the eDiscovery tools and trends have changed and how they are evolving
  • Persuading the executive management the importance of eDiscovery readiness via a comprehensive cost-benefit analysis
  • Discussing impact of technology that is evolving faster than the laws and identifying areas of increasing importance when vetting eDiscovery technologies
  • Matching the right system with the right internal team

HOW: For more information about the conference and to register, visit: www.ediscoveryevent.com/pharma/

About StoredIQ

StoredIQ is a leading provider of enterprise-class Intelligent Information Management solutions, enabling organizations to gain visibility and control over business-critical information to help meet their compliance, governance and legal discovery requirements. The company provides a range of integrated solutions for fast response to litigation and investigations, for proactive "litigation readiness," and for information protection and risk management, as well as storage management. Industry-leading companies rely on StoredIQ's award-winning technology to streamline their information management and eDiscovery processes to reduce the risk, complexity and cost of litigation. For more information, visit www.storediq.com.

StoredIQ is a trademark of StoredIQ, Inc. All other trademarks may or may not be trademarks or registered trademarks of their respective owners.


'/>"/>
SOURCE StoredIQ
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
3. Neuralstem Shares Accepted for Trading on Amex(R)
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
6. Essilor Cancels 700,000 Shares
7. Helix BioPharma announces $16.9 million private placement of common shares
8. Helix BioPharma closes $16.9 million private placement of common shares
9. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
10. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
11. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):